BioMarin Director Willard H. Dere Receives 7,490 Restricted Stock Units

This Form 4 filing reports that Willard H. Dere, a director of BioMarin Pharmaceutical Inc., received 7,490 restricted stock units on June 2, 2026. The transaction was an award of equity compensation (transaction code A) at a price of $0 per share, as these are restricted stock units. Following this transaction, Dere now holds 46,440 shares of BioMarin common stock. The filing notes that these are restricted stock units granted on June 2, 2026, and the price is not applicable. The filing was signed by attorney-in-fact Tae Sang Yoo on June 4, 2026. This represents equity compensation to a company director as part of standard director compensation arrangements.